Completed

A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

I8F-MC-GPGI - ClinicalTrials.gov - NCT04039503

The purpose of this study is to compare the safety and efficacy of the study drug tirzepatide to placebo in participants with type 2 diabetes that are already on insulin glargine, with or without metformin. Participants will administer tirzepatide or placebo along with their previous glucose lowering medications.
How long will I be in the trial?
Your participation could last about 47 weeks and may include up to 23 visits to the study center.
Email
Completed

A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

I8F-MC-GPGI - ClinicalTrials.gov - NCT04039503

The purpose of this study is to compare the safety and efficacy of the study drug tirzepatide to placebo in participants with type 2 diabetes that are already on insulin glargine, with or without metformin. Participants will administer tirzepatide or placebo along with their previous glucose lowering medications.
How long will I be in the trial?
Your participation could last about 47 weeks and may include up to 23 visits to the study center.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have type 2 diabetes

Participants must have been treated with insulin glargine (U100), once daily with or without metformin ≥3 months

Participants must have hemoglobin A1c ≥7.0% and ≤10.5%

Participants must be of stable weight

Participants must have a BMI ≥23 kilograms per meter squared (kg/m2)

Participants must NOT

Participants must not have type 1 diabetes

Participants must not have pancreatitis

Participants must not have had a heart attack, stroke, or hospitalization for congestive heart failure in the past 2 months

Participants must not have a personal or family history of medullary thyroid carcinoma or personal history of multiple endocrine neoplasia syndrome type 2

Participants must not have been taking weight loss drugs, including over-the-counter medications during the last 3 months

Trial Summary

Conditions the trial is for

Adult Type 2 Diabetes

What the trial is testing?

Tirzepatide, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

472

Trial Dates

August 2019 - January 2021

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have type 2 diabetes

Participants must have been treated with insulin glargine (U100), once daily with or without metformin ≥3 months

Participants must have hemoglobin A1c ≥7.0% and ≤10.5%

Participants must be of stable weight

Participants must have a BMI ≥23 kilograms per meter squared (kg/m2)

Participants must NOT

Participants must not have type 1 diabetes

Participants must not have pancreatitis

Participants must not have had a heart attack, stroke, or hospitalization for congestive heart failure in the past 2 months

Participants must not have a personal or family history of medullary thyroid carcinoma or personal history of multiple endocrine neoplasia syndrome type 2

Participants must not have been taking weight loss drugs, including over-the-counter medications during the last 3 months

Trial Summary

Conditions the trial is for

Adult Type 2 Diabetes

What the trial is testing?

Tirzepatide, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

472

Trial Dates

August 2019 - January 2021

Trial Phase

3

Not the right fit? Sign up to receive updates on new Adult Type 2 Diabetes trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

By clicking the checkbox and using the map, you agree to allow Google Maps to collect your personal information in accordance with their Privacy Policy

Adult Type 2 Diabetes Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?